Hummingbird Diagnostics GmbH: Hummingbird Diagnostics Announces Publication of Study on the Utility of miRisk, a Blood-based microRNA Analysis, to Predict Overall Survival for Advanced Non-Small Cell Lung Cancer in npj Precision Oncology
-Results describe development of analysis to uncover association of several microRNAs with overall survival following initiation of immunotherapy- -Blood-based test holds potential for broad applicability
Source: finanznachrichten.de